Latest Breaking News On - Corvus pharmaceuticals trading down - Page 1 : comparemela.com

William Benton Jones Purchases 20,000 Shares of Corvus Pharmaceuticals, Inc (NASDAQ:CRVS) Stock

William Benton Jones Purchases 20,000 Shares of Corvus Pharmaceuticals, Inc (NASDAQ:CRVS) Stock
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

William benton jonesCantor fitzgeraldExchange commissionNews ratings for corvus pharmaceuticals dailyCorvus pharmaceuticals trading downInstitutional trading of corvus pharmaceuticalsCorvus pharmaceuticals incCorvus pharmaceuticalsSecurities exchange commissionGet free reportPharmaceuticals trading downFree reportCorvus pharmaceuticals daily

Towerview LLC Has $500,000 Position in Corvus Pharmaceuticals, Inc (NASDAQ:CRVS)

Towerview LLC Has $500,000 Position in Corvus Pharmaceuticals, Inc (NASDAQ:CRVS)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Quarter for corvus pharmaceuticalsTucker asset managementCorvus pharmaceuticals trading downCorvus pharmaceuticalsRenaissance technologiesVirtu financialTower research capitalCorvus pharmaceuticals incNews ratings for corvus pharmaceuticals dailyExchange commissionFree reportResearch capitalStreet corpPharmaceuticals trading downGet free reportCorvus pharmaceuticals daily

Towerview LLC Has $500,000 Stock Position in Corvus Pharmaceuticals, Inc (NASDAQ:CRVS)

Towerview LLC Has $500,000 Stock Position in Corvus Pharmaceuticals, Inc (NASDAQ:CRVS)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

York mellon corpVirtu financialCharles schwab investment management incCorvus pharmaceuticals incNews ratings for corvus pharmaceuticals dailyTucker asset managementCorvus pharmaceuticalsTower research capitalCorvus pharmaceuticals trading downQuarter for corvus pharmaceuticalsSecurities exchange commissionFree reportAsset managementSchwab investment managementResearch capitalNew york mellon corp

Corvus Pharmaceuticals (NASDAQ:CRVS) Given Overweight Rating at Cantor Fitzgerald

Corvus Pharmaceuticals (NASDAQ:CRVS – Get Free Report)‘s stock had its “overweight” rating reiterated by equities researchers at Cantor Fitzgerald in a research note issued to investors on Thursday, Benzinga reports. They currently have a $4.00 price objective on the stock. Cantor Fitzgerald’s price target indicates a potential upside of 148.45% from the company’s previous close. […]

Virtu financialCantor fitzgeraldCorvus pharmaceuticals company profileCorvus pharmaceuticals trading downInstitutional trading of corvus pharmaceuticalsRenaissance technologiesNews ratings for corvus pharmaceuticals dailyCorvus pharmaceuticalsCorvus pharmaceuticals incCharles schwab investment management incTower research capitalGet free reportPharmaceuticals trading downResearch capitalStreet corpCharles schwab investment management

Corvus Pharmaceuticals (NASDAQ:CRVS) Given New $12 00 Price Target at LADENBURG THALM/SH SH

Corvus Pharmaceuticals (NASDAQ:CRVS – Free Report) had its price objective boosted by LADENBURG THALM/SH SH from $10.00 to $12.00 in a report issued on Monday, FlyOnTheWall reports. CRVS has been the topic of a number of other reports. StockNews.com began coverage on shares of Corvus Pharmaceuticals in a report on Thursday, May 18th. They set […]

Vanguard group incCorvus pharmaceuticals trading downCantor fitzgeraldMorgan stanleyAcadian asset managementRenaissance technologiesCorvus pharmaceuticals company profileNews ratings for corvus pharmaceuticals dailyInstitutional investors weigh in on corvus pharmaceuticalsCorvus pharmaceuticalsCorvus pharmaceuticals incFree reportPharmaceuticals trading downGet free reportStreet corpAsset management